drugset / Trial / NCT03033264
Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.
RandomizedParallel-groupOpen-labelTreatment
Summary
Women with a BMI\>30 and women with a BMI\<30 will be divided in a randomized controlled manor to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files.
Timeline
- Start
- 2017-01-01
- Primary completion
- 2020-07-31
- Completion
- 2020-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 10 mg | Intravenous |
Indications
No indication recorded.